Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. financial statements

Kailera Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 148.96MEODHD
Cash and equivalentsUSD 160.27MEODHD
Total debtUSD 10.75MEODHD

Kailera Therapeutics, Inc. financials on 6ix · Kailera Therapeutics, Inc. on 6ix